Gene Query: WDR75

Dataset Description Geneva Score
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 34.45
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 34.23
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 22.77
Transcriptomic analyssis following EHMT1/2 inhibition 22.67
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 22.4
LNCaP treated with iBET 22.14
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 21.63
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 21.56
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 20.79
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 20.76
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 19.88
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 18.92
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 18.86
ETV7 and interferon response 18.86
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 18.74
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 18.7
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 18.7
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 18.64
IDH3a KO RNA-seq 18.28
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 17.99
Developmental stage specific chromosome architecture in human erythroid cells 17.53
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 17.53
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 17.08
A transcriptome-wide divergence in protein translation scales with LIN28B expression 16.12
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 16.11
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 16.1
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 15.43
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 15.35
FBXW7 modulates stress response by post-translational modification of HSF1 15.35
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 15.23
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 14.55
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 14.55
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 14.32
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 14.32
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 14.11
Seletive inhibition of CDK9 in DLBCL cell lines 13.95
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 13.85
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 13.43
Lysine benzoylation is a novel histone mark [RNA-seq] 13.42
Lysine benzoylation is a novel histone mark 13.42
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 13.34
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 13.13
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 12.93
Human HAP1 cells before and after nutrient deprivation 12.93
RNA-seq analysis of RALD iPSCs after in vitro differentiation 12.87
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 12.79
Regulation of protein translation during mitosis 12.77
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 12.55
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 12.48
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 12.39
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 12.05
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 11.75
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 11.67
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 11.52
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 11.47
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 11.45
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 11.28
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 11.26
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 11.26
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 11.02
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 11.02
The landscape of alternative splicing in aggressive prostate cancers 10.97
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 10.95
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 10.83
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 10.82
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 10.79
3’ Uridylation Expands miRNA Target Repertoire 10.75
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 10.72
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 10.68
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 10.42
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 10.42
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 10.33
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 10.18
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 10.17
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 10.09
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 10.02
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 9.99
Trans-differentiation of human adult peripheral blood T cells into neurons 9.94
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 9.9
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 9.84
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 9.72
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 9.69
Regulation of highly expressed hCINAP on translatome 9.66
Human cell line and subcutaneous tumor 9.53
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 9.44
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 9.18
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 9.07
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 9.05
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 9.02
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 8.91
Genome-wide discovery of human splicing branchpoints 8.86
R430: A potent inbibitor of DNA and RNA viruses 8.83
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 8.78
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 8.75
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 8.75
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 8.73
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 8.73
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 8.65
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 8.64
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 8.57
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 8.57
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 8.54
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 8.52
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 8.48
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 8.35
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 8.33
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 8.33
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 8.31
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 8.31
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 8.3
Cerebellar differentiation in Ataxia-Telangiectasia 8.28
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 8.27
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 8.22
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 8.21
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 8.19
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 8.18
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 8.17
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 8.17
Differentially expressed vascular development genes for iPSC-ECs from CDI 8.12
A Unique Epigenomic Landscape Defines Human Erythropoiesis 8.1
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 8.1
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 8.1
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 8.1
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 8.06
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 8.02
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 8.02
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 8.0
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 7.96
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 7.96
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 7.94
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 7.92
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 7.91
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 7.88
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 7.8
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 7.8
RNA-seq analysis of differentiating human erythroblasts 7.76
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 7.75
Effect of Hotair overexpression in human breast cancer cell lines 7.74
ARID1A regulates condensin II distribution and chromosomal partition 7.74
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 7.74
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 7.73
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 7.71
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 7.69
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 7.69
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 7.57
Primary Human B-cell Temporal Response to CD40L Stimulation 7.56
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 7.56
Nucleoporin-mediated regulation of cell identity genes 7.51
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 7.47
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 7.47
High-efficiency RNA-based reprogramming of human primary fibroblasts 7.47
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 7.43
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 7.4
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 7.39
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 7.34
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 7.34
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 7.32
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 7.3
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 7.3
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 7.3
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 7.29
MYC dependent mRNA translation shapes gene expression and cell biology 7.21
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 7.14
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 7.13
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 7.12
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 7.11
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 7.09
Co-transcriptional loading of RNA export factors shapes the human transcriptome 7.08
RNAseq of HEK293 cells after Chtop knockdown 7.08
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 7.08
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 7.06
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 7.02
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 7.01
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 7.01
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 7.0
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 6.91
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 6.91
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 6.9
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 6.84
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 6.82
BASP1 modifies the Tamoxifen response 6.77
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 6.75
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 6.73
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 6.73
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 6.73
Identification of transcription start sites for human A549 cell line using ReCappable-seq 6.67
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 6.67
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 6.67
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 6.66
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 6.61
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 6.6
hTERT promotes cell adhesion and migration independent of telomerase activity 6.59
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 6.57
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 6.57
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 6.56
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 6.55
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 6.55
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 6.55
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 6.52
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 6.51
Capturing the Interactome of Newly Transcribed RNA (RICK) 6.5
Capturing the Interactome of Newly Transcribed RNA 6.5
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 6.5
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 6.49
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 6.49
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 6.47
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 6.45
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 6.45
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 6.43
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 6.4
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 6.38
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 6.37
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 6.35
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 6.32
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 6.3
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 6.3
IMP3 regulated gene expression in breast cancer cells 6.26
Genome-wide discovery of human splicing branchpoints [RNAse] 6.23
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 6.15
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 6.15
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 6.15
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 6.15
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 6.13
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 6.13
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 6.12
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 6.11
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 6.08
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 6.06
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 6.03
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 6.03
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 6.03
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 6.03
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 6.0
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 5.98
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 5.98
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 5.97
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 5.95
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 5.88
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 5.87
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 5.87
RNA-seq of RKO cells with cTAZ KO or putback 5.85
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 5.83
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 5.75
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 5.73
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 5.7
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 5.68
Functional role of SLIT2 and ROBO1 in trophoblasts 5.65
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 5.64
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 5.64
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 5.62
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 5.62
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 5.57
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 5.55
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 5.54
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 5.54
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 5.54
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 5.5
LncRNA expression profiling of ischemic stroke patients 5.46
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 5.42
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 5.36
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 5.3
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 5.3
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 5.24
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 5.23
LIN28A Over-expression RNAseq 5.22
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 5.19
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 5.19
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 5.19
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 5.18
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 5.18
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 5.18
RNA-seq of MDA-MB-231 cells with TET1 knockout 5.16
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 5.15
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 5.11
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 5.11
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 5.1
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 5.07
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 5.07
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 5.04
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 5.04
SLIGRL-induced gene expression changes in NHEK cells 5.02
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 5.0
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 4.93
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 4.93
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 4.83
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 4.83
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 4.83
Global Mapping of Human RNA-RNA Interactions 4.81
Transcriptome landscape of HeLa response upon triamcinolone acetonide 4.73
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 4.72
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 4.71
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 4.71
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 4.71
EWSR1 influences alternative splicing through direct and indirect mechanisms 4.63
Transcriptome of U251 cells overexpression complement component 7 4.62
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 4.62
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 4.62
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 4.62
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 4.61
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 4.61
Molecular Criteria for Defining the Naive Human Pluripotent State 4.61
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 4.57
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 4.57
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 4.55
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 4.55
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 4.54
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 4.53
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 4.47
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 4.46
Transcriptomic analysis of ERR alpha orphan nuclear receptor 4.43
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 4.42
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 4.38
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 4.37
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 4.36
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 4.36
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 4.36
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 4.28
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 4.24
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 4.24
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 4.24
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 4.24
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 4.2
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 4.2
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 4.19
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 4.17
RNA sequencing of primary human platelets and in vitro cell lines 4.09
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 4.06
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 4.03
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 4.03
Transcriptional responses of melanoma cells to BRAF inhibition 3.99
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 3.93
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 3.93
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 3.93
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 3.93
RNA sequencing of human mammary epithelial cells 3.91
p53 activity results in DNA replication fork processivity 3.9
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 3.85
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 3.84
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 3.81
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 3.81
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 3.78
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 3.78
Exploring ILF2 regulatory genes by next-generation sequencing 3.77
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 3.73
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 3.72
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 3.7
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 3.66
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 3.65
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 3.62
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 3.54
The Genetic Landscape of Diamond-Blackfan Anemia 3.45
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 3.44
Human cells contain natural double-stranded RNAs with potential regulatory capacity 3.43
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 3.4
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.4
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 3.36
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 3.36
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 3.33
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 3.33
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 3.24
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 3.24
A map of gene expression in neutrophil-like cell lines 3.23
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 3.22
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 3.21
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 3.17
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 3.16
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 3.13
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 3.05
Co-regulation of splicing by Rbfox1 and hnRNP M 3.05
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 3.01
Gene expression profile in breast cancer cells 2.98
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 2.98
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 2.93
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 2.9
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 2.87
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 2.81
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 2.79
single cell RNA-seq from GM12878 (ENCSR673UIY) 2.7
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.64
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 2.59
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 2.53
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 2.53
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 2.52
CDK12 mediated transcriptional regulation in U2OS cells 2.52
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  2.5
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 2.5
RNA seq with AML (NB4) cells upon FTO inhibition 2.49
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.48
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.48
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 2.38
6mer seed toxicity in viral microRNAs 2.38
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 2.31
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 2.31
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 2.3
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 2.27
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 2.27
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 2.26
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 2.23
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.22
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 2.2
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 2.2
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 2.15
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 2.15
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 2.08
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 2.06
HEK293 TFAM Knockout Expression Study 2.02
Human Treg NaCl stimulation 2.01
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 2.01
Human Treg IL-12 stimulation 2.0
Mapping interactions for the TNIP2 hub protein 1.93
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 1.92
EWS-Fli and LNC regulated genes in comparison to GFP samples 1.84
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 1.79
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 1.79
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 1.78
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 1.75
The contribution of Alu exons to the human proteome 1.74
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 1.73
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 1.72
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 1.67
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 1.67
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 1.65
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 1.64
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 1.5
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.47
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 1.43
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 1.42
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 1.4
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.39
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.39
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 1.39
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 1.39
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.34
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 1.33
Gene expression profiling in metabolically heterogeneous human lung tumors 1.31
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 1.29
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 1.26
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.22
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.22
HBEC-shp53-PCHD7 1.19
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 1.17
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 1.17
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 1.12
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 1.11
Impact on erythroid progenitor type on erythroid differntiation 1.1
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 1.07
WNT signaling memory is required for ACTIVIN to function as a morphogen 1.07
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 1.06
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 1.06
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.04
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 1.04
RNA sequencing with KSHV infection and enrichment for circular RNAs 1.0
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 0.96
TOP2B disturbed the quality of human oocytes with advanced maternal age 0.96
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.95
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.95
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.93
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.92
The MEF2B Regulatory Network 0.92
The MEF2B Regulatory Network - RNA-seq data 0.92
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.88
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 0.87
Small-molecule targeting of brachyury transcription factor addiction in chordoma 0.81
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 0.77
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 0.71
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.69
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.69
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.65
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.63
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.61
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.56
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.51
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.47
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.47
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.46
Modulation of nonsense-mediated decay by rapamycin 0.43
siRNA-mediated knockdown 0.42
Myc activation coordinates gene transcription and protein translation responses 0.35
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.32
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.3
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 0.29
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 0.27
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 0.27
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 0.25
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.25
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.2
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.18
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.17
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.17
Transcriptional landscape changes during human embryonic stem cell derivation 0.1
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.09
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 0.06
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 0.06
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.06
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 0.05
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.04
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.04
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.02
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.01
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation